Briefly, the test determines if the PTEN gene is functioning properly, as it is a tumor suppressor gene that is linked with cell regulation. If patients have a low level of the protein, studies have shown a progression of the cancer, while if the levels remain higher, the less chances of...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
12-22-2008
Filed under:
Filed under: Medically Related, Insurance, Pharma/FDA News, personalized medicine, Genomics, healthcare, Cancer, tumors, Chemotherapy, markers, PTEN gene, Myriad, diagnositic tests
This is not ready for prime time yet, but a new technique under development from Phillips to help with chemotherapy in targeting the cancer cells directing, thus less of the drug going through the rest of the healthy tissue of the body where it is not needed. Localizing chemotherapy without the...
The software receives demographics, lab results, medication and allergy lists, and height and weight data and sends detailed prescribing and nurse note information, as well as individual drug administrations. The software can also maintain complete medical charts. All the the software requires...
Being this is breast cancer awareness month, nice feature on Elizabeth Edwards and how she not only is battling breast cancer, but the public display of her marriage, which she has pretty much kept under wrap. Cancer is tough enough to battle as it is, but add on the other side of what happened...
Wow, huge bills and she was able to borrow 45k but then at admitting time, the hospital wanted another 65k. This was at the MD Anderson Center in Texas. She states that she could pay for her chemotherapy if she washes out here entire retirement funds, tough decision and so now she keeps fighting...
The new vaccine, Lucanix, is genetically engineered to also trick the cancer into turning off its immune system-suppressing activities, this is a turn in a different direction here where vaccines are normally increase the immune system capabilities. The project is enrolling 700 patients at 90 centers...
Great interview from the Wall Street Journal, I guess when it comes time to go over the costs a patient gets to select to either find a method of payment if they can, or the other choice (no treatment) and we all know what the horrible results can be from there. The physicians are there to treat...